Intel Capital, the corporate venturing division of US-listed chip maker Intel, is expected to sell 6.45 million shares, 2.2%, of ChinaCache at its flotation.

Euronext-listed biotech company TiGenix supports seed round of its spin-out, TR-therapeutics, after its merger with Therosteon to form Arcarios.

Listing of biotechnology group Pacific Biosciences comes a month after bumper series F round.

Indian retail conglomerate Future Group restarts listing process for its corporate venturing unit.

IDG-Accel-backed Kanghui prices in middle of its initial public offering range in New York.

India-based corporate venturing unit Future Ventures to restart flotation plans on August 11.

Safeguard Scientifics and SR One-baved drugs company NuPathe amends listing price to $10 per share.

Chinese maker of orthopedic implants backed by US media company International Data Group's local venture fund, IDG-Accel, starts $75m flotation process.